7.3 C
New York
Thursday, January 15, 2026

First Alzheimer’s pill for genetically at high risk shows promise in phase 3 trial

While researchers still do not know what exactly causes the type of dementia called Alzheimer’s disease, past studies show that genetics can play an important role. One gene variant that is particularly associated with Alzheimer’s disease risk is APOE4. Researchers estimate that between 15-25% of …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

149,694FansLike
396,312FollowersFollow
2,640SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x